106 related articles for article (PubMed ID: 1909935)
21. Relationship between structure and activity of aspirin-related compounds on the inhibition of in vitro platelet aggregation.
Dupin JP; Gravier D; Casadebaig F; Boisseau MR; Bernard H
Farmaco Sci; 1986 Mar; 41(3):205-14. PubMed ID: 3086120
[TBL] [Abstract][Full Text] [Related]
22. [Inhibitory effect of TBN on platelet aggregation in rabbit].
Xu CL; Shan LC; Sun YW; Wang YQ
Zhong Yao Cai; 2010 Sep; 33(9):1450-3. PubMed ID: 21243778
[TBL] [Abstract][Full Text] [Related]
23. Sulphonylurea agents inhibit platelet aggregation and [Ca2+]i elevation induced by arachidonic acid.
Qi R; Ozaki Y; Satoh K; Kurota K; Asazuma N; Yatomi Y; Kume S
Biochem Pharmacol; 1995 Jun; 49(12):1735-9. PubMed ID: 7598735
[TBL] [Abstract][Full Text] [Related]
24. [Autoxidation products of arachidonic acid modify the arachidonic acid-induced aggregation of human blood platelets].
Lösche W; Michel E; Till U
Z Med Lab Diagn; 1984; 25(2):104-7. PubMed ID: 6426184
[No Abstract] [Full Text] [Related]
25. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor.
Carmo LG; Hatmi M; Rotilio D; Vargaftig BB
Br J Pharmacol; 1985 Aug; 85(4):849-59. PubMed ID: 2994786
[TBL] [Abstract][Full Text] [Related]
26. Triphenyltin fluoride in vitro inhibition of rabbit platelet collagen-induced aggregation and ATP secretion and blockade of arachidonic acid mobilization from membrane phospholipids.
Manabe S; Wada O; Matsui H; Takada M; Kobayashi N; Maekawa T
Biochem Pharmacol; 1983 May; 32(10):1627-34. PubMed ID: 6305366
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of H2-receptor antagonists on platelet function in vitro.
Nakamura K; Kariyazono H; Shinkawa T; Yamaguchi T; Yamashita T; Ayukawa O; Moriyama Y; Yotsumoto G; Toyohira H; Taira A; Yamada K
Hum Exp Toxicol; 1999 Aug; 18(8):487-92. PubMed ID: 10462360
[TBL] [Abstract][Full Text] [Related]
28. Platelet aggregation: inhibition of secondary aggregation by phenol.
Coan ML; Case KR; Bosmann HB
Res Commun Chem Pathol Pharmacol; 1982 May; 36(2):241-9. PubMed ID: 6808618
[TBL] [Abstract][Full Text] [Related]
29. ESR analysis with long-chain alkyl spin labels in bovine blood platelets. Relationship between the increase in membrane fluidity by alcohols and phenolic compounds and their inhibitory effects on aggregation.
Kitagawa S; Kametani F; Tsuchiya K; Sakurai H
Biochim Biophys Acta; 1990 Aug; 1027(2):123-9. PubMed ID: 2168753
[TBL] [Abstract][Full Text] [Related]
30. Miconazole inhibition of platelet aggregation by inhibiting cyclooxygenase.
Ishikawa S; Manabe S; Wada O
Biochem Pharmacol; 1986 Jun; 35(11):1787-92. PubMed ID: 3087363
[TBL] [Abstract][Full Text] [Related]
31. Influence of aspirin, molsidomine, trapidil, and some trapidil derivatives on arachidonic acid induced reversible thrombocyte aggregation in the rabbit.
Zehl U; Mest HJ; Förster W
Biomed Biochim Acta; 1984; 43(8-9):S381-4. PubMed ID: 6440554
[TBL] [Abstract][Full Text] [Related]
32. Platelet aggregation inhibitors from Populus sieboldii Miquel.
Kagawa K; Tokura K; Uchida K; Kakushi H; Shike T
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2191-2. PubMed ID: 1423779
[TBL] [Abstract][Full Text] [Related]
33. [Studies on as-triazine derivatives. XVIII. Synthesis of 5,6-diaryl-1,2,4-triazine derivatives as blood platelet aggregation inhibitors].
Konno S; Kokubo T; Amano M; Yoshida N; Sagi M; Yamanaka H
Yakugaku Zasshi; 1992 Oct; 112(10):729-41. PubMed ID: 1469603
[TBL] [Abstract][Full Text] [Related]
34. Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619.
Hatmi M; del Maschio A; Lefort J; de gaetano G; Vargaftig BB; Cerletti C
J Pharmacol Exp Ther; 1987 May; 241(2):623-7. PubMed ID: 3106620
[TBL] [Abstract][Full Text] [Related]
35. Modulation of arachidonic acid metabolism by phenols: relation to positions of hydroxyl groups and peroxyl radical scavenging properties.
Alanko J; Riutta A; Mucha I; Vapaatalo H; Metsä-Ketelä T
Free Radic Biol Med; 1993 Jan; 14(1):19-25. PubMed ID: 8384148
[TBL] [Abstract][Full Text] [Related]
36. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
Block HU; Förster W; Heinroth I
Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
[TBL] [Abstract][Full Text] [Related]
37. Antiplatelet activity of some prenylflavonoids.
Lin CN; Shieh WL; Ko FN; Teng CM
Biochem Pharmacol; 1993 Jan; 45(2):509-12. PubMed ID: 8435100
[TBL] [Abstract][Full Text] [Related]
38. Azaprostanoic acid derivatives. Inhibitors of arachidonic acid induced platelet aggregation.
Venton DL; Enke SE; Le Breton GC
J Med Chem; 1979 Jul; 22(7):824-30. PubMed ID: 109614
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation.
Mori K; Kikuchi H; Obara Y; Iwashita M; Azumi Y; Kinugasa S; Inatomi S; Oshima Y; Nakahata N
Phytomedicine; 2010 Dec; 17(14):1082-5. PubMed ID: 20637576
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of baicalein derivatives as potential anti-aggregatory and anti-inflammatory agents.
Huang WH; Lee AR; Chien PY; Chou TC
J Pharm Pharmacol; 2005 Feb; 57(2):219-25. PubMed ID: 15720786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
